CELG Hearing chatter of activist investor building a stake

Third Point rumored to be building a stake and possibly pushing for a sale

News: CELG Hearing chatter of activist investor building a stake- Third Point rumored to be building a stake and possibly pushing for a sale

Time: Wednesday, March 07, 2018 10:13

Intraday Maximum Change: $0.995 - 1.098% Minutes After: 8

Latest Quote: 79.14 Change Since: $-10.475 - -13.24% Days Since: 107

Snapshot of company's key stats at the time of the event

Market Cap: 69,617,613,398 Shares Outstanding: 752,175,608 Float: 748,486,884

Day's Short Interest: 16,748,396 Short Ratio: 2.12%

Institutional Ownership: 46% Insider Ownership: 0.5%

CELG - Celgene Corporation

Sector: Healthcare - Industry: Biotechnology

Celgene Corp is a biotech company that discovers, develops, and commercializes therapies designed to treat cancer and immune-inflammatory related diseases. Its registered brands are Abraxane, Istodax, Otezla, Pomalyst, Revlimid, Thalomid, Vidaza.

Leave a Reply

Your email address will not be published. Required fields are marked *